Nicole Weckman (ISTEP, ChemE) is the Paul Cadario Chair in Global Engineering at the University of Toronto. Her research focuses on developing the next generation of point-of-care technologies for diagnosing diseases and monitoring outbreaks of drug-resistant infections. Her research group develops sensitive and quantitative biological and biochemical sensors at the interface of cell-free synthetic biology and microscale and nanoscale sensing systems by focusing on engineering design for clinical and commercial translation. She is particularly interested in developing low-cost and sustainable diagnostics that can help to improve health equity. Beyond her academic work, Dr. Weckman is co-founder of the start-up 52 North Health, where she is working in the medical diagnostic space to develop low-cost digitally linked technologies that help improve health outcomes and health equity for people receiving chemotherapy.